FDA registration vs approval is a distinction that trips up many first-time importers and distributors, and the confusion is understandable — both terms involve the US Food and Drug Administration, both are prerequisites for certain market activities, and both appear in supplier marketing materials. But they refer to fundamentally different things: registration is an administrative listing requirement for facilities and distributors, while approval or clearance is a device-specific regulatory determination. Understanding the difference matters for any company importing devices into the United States, since conflating the two can create compliance gaps or, worse, mislead customers about a device's actual regulatory status.
What Does FDA Establishment Registration Actually Mean?
FDA establishment registration is a requirement for domestic and foreign facilities involved in producing, distributing, or handling medical devices intended for the US market, including manufacturers, distributors, and certain other supply chain participants. Registering an establishment means that entity is listed in the FDA's registration database and has provided the agency with required information about its facility and activities. Registration by itself does not evaluate or endorse the safety or effectiveness of any specific device — it is an administrative and traceability mechanism, not a quality or safety judgment. A company can be a fully FDA-registered establishment while the individual devices it distributes each carry their own separate, and sometimes still-pending, regulatory status.
How Does Device Listing Fit Into This Framework?
Alongside establishment registration, device listing is the process by which specific devices are recorded in the FDA's system as being marketed by a given registered establishment. Listing a device again does not mean the FDA has reviewed or approved that device — it is a notification and tracking function, distinct from any premarket review pathway (such as 510(k) clearance, De Novo classification, or premarket approval) that a device may separately need depending on its risk classification. Importers should understand that seeing a device appear in the FDA listing database confirms only that it has been declared to the agency by a registered entity, not that the device has cleared a premarket safety and effectiveness review.
Why Does This Distinction Matter for Marketing and Compliance?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
What Should Importers Verify Before Bringing a Device Into the US Market?
Importers should confirm the specific premarket pathway, if any, that applies to a device's risk classification, verify that both the manufacturer's foreign facility and the US-based distributor maintain current FDA registration, and ensure device listing records are accurate and current. Working with legal or regulatory counsel familiar with FDA device requirements is generally advisable before finalizing an import or distribution agreement, since misclassifying a device's regulatory pathway can create significant compliance exposure. Precision in describing a device's status — registered, listed, cleared, or approved, as applicable — protects both the importer and the clinicians and patients who ultimately use the device.
What should a distributor confirm before marketing a device as "FDA registered"?
A distributor should confirm precisely what registration status applies — establishment registration, device listing, or an actual premarket clearance or approval — and use accurate language reflecting that status rather than implying a higher level of regulatory review than has actually occurred. Reviewing marketing claims with regulatory counsel is a prudent step before publishing them.